Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA425285
Max Phase: Preclinical
Molecular Formula: C27H34Cl2N6O
Molecular Weight: 529.52
Molecule Type: Small molecule
Associated Items:
ID: ALA425285
Max Phase: Preclinical
Molecular Formula: C27H34Cl2N6O
Molecular Weight: 529.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1
Standard InChI: InChI=1S/C27H34Cl2N6O/c1-2-9-24-26(31-32-35(24)20-21-10-4-3-5-11-21)27(36)30-14-6-7-15-33-16-18-34(19-17-33)23-13-8-12-22(28)25(23)29/h3-5,8,10-13H,2,6-7,9,14-20H2,1H3,(H,30,36)
Standard InChI Key: HEKOGNYDDZRAAJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 529.52 | Molecular Weight (Monoisotopic): 528.2171 | AlogP: 4.92 | #Rotatable Bonds: 11 |
Polar Surface Area: 66.29 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.02 | CX Basic pKa: 7.33 | CX LogP: 5.91 | CX LogD: 5.65 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.36 | Np Likeness Score: -1.82 |
1. Salama I, Hocke C, Utz W, Prante O, Boeckler F, Hübner H, Kuwert T, Gmeiner P.. (2007) Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands., 50 (3): [PMID:17266201] [10.1021/jm0611152] |
2. Möller D, Salama I, Kling RC, Hübner H, Gmeiner P.. (2015) 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation., 23 (18): [PMID:26299826] [10.1016/j.bmc.2015.07.050] |
Source(1):